Cargando…

Teriparatide treatment in severe osteoporosis – a controlled 10-year follow-up study

BACKGROUND: Teriparatide was the first anabolic agent recommended for the treatment of osteoporosis. Long-term real-world, controlled studies are not available. The purpose was to evaluate the long-term effects of treatment with teriparatide on fractures and Health Related Quality of Life in subject...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kontogeorgos, Georgios, Krantz, Emily, Trimpou, Penelope, Laine, Christine M., Landin-Wilhelmsen, Kerstin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686095/ https://www.ncbi.nlm.nih.gov/pubmed/36424580 http://dx.doi.org/10.1186/s12891-022-05987-2

Ejemplares similares

Low health-related quality of life in hypoparathyroidism and need for PTH analog
por: Kontogeorgos, Georgios, et al.
Publicado: (2021)

Normocalcaemic, vitamin D‐sufficient hyperparathyroidism – high prevalence and low morbidity in the general population: A long‐term follow‐up study, the WHO MONICA project, Gothenburg, Sweden
por: Kontogeorgos, Georgios, et al.
Publicado: (2015)

Health-Related Quality of Life in Turner Syndrome and the Influence of Growth Hormone Therapy: A 20-Year Follow-Up
por: Krantz, Emily, et al.
Publicado: (2019)

Comparison between different instruments for measuring health-related quality of life in a population sample, the WHO MONICA Project, Gothenburg, Sweden: an observational, cross-sectional study
por: Krantz, Emily, et al.
Publicado: (2019)

Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up
por: Laine, C. M., et al.
Publicado: (2017)

Comorbidity and quality of life in obesity–a comparative study with the general population in Gothenburg, Sweden
por: Mejaddam, Ala, et al.
Publicado: (2022)

Hearing and Balance Exceed Initial Bone Mineral Density in Predicting Incident Fractures: A 25‐Year Prospective Observational Study in Menopausal Women With Osteoporosis
por: Dotevall, Annika, et al.
Publicado: (2021)

High androgen levels protect against hypothyroidism
por: Schmidt, Johanna, et al.
Publicado: (2016)

Iodine Status After Bariatric Surgery—a Prospective 10-Year Report from the Swedish Obese Subjects (SOS) Study
por: Manousou, Sofia, et al.
Publicado: (2017)

Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls
por: Forslund, Maria, et al.
Publicado: (2018)

Comorbidity and health-related quality of life in Somali women living in Sweden
por: Demeke, Taye, et al.
Publicado: (2019)

Teriparatide in the management of osteoporosis
por: Bodenner, Donald, et al.
Publicado: (2007)

Teriparatide – Indications beyond osteoporosis
por: Cheng, Marilyn Lee, et al.
Publicado: (2012)

Therapy of Osteoporosis in Men with Teriparatide
por: Cusano, Natalie E., et al.
Publicado: (2011)

Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution
por: Forslund, M, et al.
Publicado: (2020)

Profile of teriparatide in the management of postmenopausal osteoporosis
por: Sikon, Andrea, et al.
Publicado: (2010)

Teriparatide for osteoporosis: importance of the full course
por: Lindsay, R., et al.
Publicado: (2016)

Treatment of osteoporosis with teriparatide: The Slovenian experience
por: Kocjan, Tomaz, et al.
Publicado: (2021)

Vertebral Collapse Prevented Following Teriparatide Treatment in Postmenopausal Kümmell's Disease Patients with Severe Osteoporosis
por: Gou, Peng‐guo, et al.
Publicado: (2021)

Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
por: Gupta, Vishal
Publicado: (2013)

Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis
por: Taheri, Saeed, et al.
Publicado: (2019)

THU441 Teriparatide As Treatment For Severe Osteoporosis In Lung Transplant Recipients
por: Muir, Christopher Alan, et al.
Publicado: (2023)

Management of glucocorticoids-induced osteoporosis: role of teriparatide
por: Migliaccio, Silvia, et al.
Publicado: (2009)

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
por: Lau, Arthur N, et al.
Publicado: (2010)

A Case of Teriparatide on Pregnancy-Induced Osteoporosis
por: Lee, Seok Hong, et al.
Publicado: (2013)

Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
por: Minisola, Salvatore, et al.
Publicado: (2019)

Treatment responses with once-weekly teriparatide therapy for osteoporosis
por: Shiraki, M., et al.
Publicado: (2016)

Weekly Teriparatide Therapy Rapidly Accelerates Bone Healing in Pyogenic Spondylitis with Severe Osteoporosis
por: Shinohara, Akira, et al.
Publicado: (2014)

Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment
por: Hirooka, Yasuaki, et al.
Publicado: (2021)

Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment
por: Gagnon, Claudia, et al.
Publicado: (2008)

Synthesis and anti-osteoporosis activity of novel Teriparatide glycosylation derivatives
por: Wang, Nan, et al.
Publicado: (2020)

Primary hyperparathyroidism associated with vitamin D toxicity in a patient with severe osteoporosis receiving teriparatide
por: Gupta, Vishal, et al.
Publicado: (2012)

Cumulative incidence and predictors of acquired aortic stenosis in a large population of men followed for up to 43 years
por: Kontogeorgos, Silvana, et al.
Publicado: (2022)

Severe hypercalcemia due to teriparatide
por: Karatoprak, Cumali, et al.
Publicado: (2012)

Improvement in health-related quality of life in osteoporosis patients treated with teriparatide
por: Lau, Arthur N, et al.
Publicado: (2008)

PINP as a biological response marker during teriparatide treatment for osteoporosis
por: Krege, J. H., et al.
Publicado: (2014)

Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy
por: Xie, Zhongjian, et al.
Publicado: (2019)

OA07 A case of severe osteoporosis treated with teriparatide following the development of bilateral atypical femoral fractures due to IV zoledronic acid
por: Rosa, Chamith, et al.
Publicado: (2023)

Effectiveness of Teriparatide in Women Over 75 Years of Age with Severe Osteoporosis: 36-Month Results from the European Forsteo Observational Study (EFOS)
por: Walsh, J. Bernard, et al.
Publicado: (2012)

Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis
por: Moore, Amelia E. B., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_opvlthggkvjacac3ut8suo9juq